Laval, Canada

Sylvain Daigneault



Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Quebec, CA (2007)
  • Laval, CA (2006 - 2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Sylvain Daigneault: Innovator in Antineoplastic Combinations

Introduction

Sylvain Daigneault is a notable inventor based in Laval, Canada. He has made significant contributions to the field of medicine, particularly in the development of antineoplastic combinations. With a total of 6 patents to his name, Daigneault's work has the potential to impact cancer treatment significantly.

Latest Patents

One of Daigneault's latest patents focuses on antineoplastic combinations. This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms. This innovative approach aims to enhance the effectiveness of cancer therapies and improve patient outcomes.

Career Highlights

Daigneault is currently employed at Wyeth, a company known for its commitment to advancing healthcare through innovative solutions. His work at Wyeth has allowed him to collaborate with other talented professionals in the field, furthering the development of groundbreaking treatments.

Collaborations

Some of his notable coworkers include Scott Mason Duncan and John Leo Considine. Their collective expertise contributes to the innovative environment at Wyeth, fostering advancements in medical research and development.

Conclusion

Sylvain Daigneault's contributions to the field of antineoplastic combinations highlight his dedication to improving cancer treatment. His innovative spirit and collaborative efforts at Wyeth continue to pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…